Aesthetic manufacturer Caromed Italia has announced that ElysiHA will be officially launching at the Clinical Cosmetic Regenerative Congress (CCR) 2026.
According to Caromed Italia, ElysiHA is a topical formulation, developed to support skin quality in individuals undergoing pharmacological weight loss. Its formulation combines polydeoxyribonucleotide (PDRN), dual molecular-weight hyaluronic acid (HA), recombinant collagen, ectoin and copper peptide GHK-Cu to support hydration, barrier function and collagen-related signalling.
Massimiliano Candini, Caromed Italia brand and business development director commented, “Caromed Italia is proud to announce the global launch of ElysiHA, the next evolution of regenerative science, balancing key actives that target and enhance the PDRN regenerative compound for each area. ElysiHA face pairs recombinant collagen for structure with dual-molecular-weight HA for hydration; the eye formula refines the same core to target dark circles and under-eye bags – a natural approach to slowing ageing.”